Stay updated on GM T-cell Therapy in AML/BPDCN Clinical Trial

Sign up to get notified when there's something new on the GM T-cell Therapy in AML/BPDCN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GM T-cell Therapy in AML/BPDCN Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, signaling a new release of the page content.
    Difference
    0.0%
    Check dated 2026-05-15T15:47:54.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:02:15.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:52.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    No additions or deletions were reported for the page.
    Difference
    0.0%
    Check dated 2026-04-09T21:34:37.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Added Acute lymphoid leukemia and CD4+/CD56+ hematodermic neoplasm to the conditions/MeSH terms. This broadens indexing but does not modify the trial's design, eligibility criteria, interventions, or other essential details.
    Difference
    0.1%
    Check dated 2026-04-02T15:31:27.000Z thumbnail image
  9. Check
    78 days ago
    Change Detected
    Summary
    Revision changed from v3.4.3 to v3.5.0. The previous revision entry v3.4.3 was removed and a new entry v3.5.0 was added.
    Difference
    0.0%
    Check dated 2026-03-19T06:08:25.000Z thumbnail image

Stay in the know with updates to GM T-cell Therapy in AML/BPDCN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GM T-cell Therapy in AML/BPDCN Clinical Trial page.